Effect of dosage failed of first antiepileptic drug on subsequent outcome
Open Access
Abstract
Summary: Purpose: The recent definition of drug‐resistant epilepsy proposed by the International League Against Epilepsy (ILAE) stipulated failure of an adequate trial of two tolerated, appropriately chosen and used antiepileptic drug (AED) schedules to achieve seizure freedom. Doses failed were not specifically discussed. We explored the effect of the doses at which the first and second AED regimens failed on subsequent outcomes in a population of adults with newly diagnosed epilepsy followed for up to 20 years.Methods: Patients in whom epilepsy was diagnosed and the first AED prescribed between July 1, 1982 and April 1, 2006, were followed until March 31, 2008. Dosage at which an AED failed was categorized according to the World Health Organization’s defined daily dose (DDD) for each drug. Cumulative incidence curves for time to final seizure freedom (no seizure for at least 1 year on unchanged dosage at last follow up) were stratified by whether the first regimen was failed at doses above or below the 25%, 50%, or 75% cutoffs for the DDD of each AED.Key Findings: Among patients who had taken a second regimen (n = 327), those in whom the first AED failed at doses above the various cutoffs (particularly 50% and 75% DDD) had lower probability of becoming seizure‐free at last follow‐up (p = 0.06 for 25% DDD, p < 0.001 for both 50% and 75% DDD). The same difference was observed for patients who had taken a third regimen (n = 141; p = 0.23 for 25% DDD, p < 0.01 for 50% DDD; and p = 0.002 for 75% DDD). A trend to higher seizure‐free rate was observed in patients who had taken the third regimen when both the first and second regimens failed at Significance: Higher failure dosage of the first AED predicts poorer subsequent outcome. This methodology could be used to refine further the ILAE definition of drug‐resistant epilepsy by exploring the doses need to fail to provide an adequate AED trial.Keywords
This publication has 16 references indexed in Scilit:
- Patterns of treatment response in newly diagnosed epilepsyNeurology, 2012
- Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug‐refractory epilepsyEpilepsia, 2010
- Identification of Pharmacoresistant EpilepsyNeurologic Clinics, 2009
- Risk of digoxin intoxication caused by clarithromycin–digoxin interactions in heart failure patients: a population-based studyEuropean Journal of Clinical Pharmacology, 2009
- Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsyNeurology, 2007
- In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugsBritish Journal of Clinical Pharmacology, 2006
- Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switchSeizure: European Journal of Epilepsy, 2004
- Response to first drug trial predicts outcome in childhood temporal lobe epilepsyNeurology, 2001
- Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse EffectsEpilepsia, 1997
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988